MANTI, ANTONIA
 Distribuzione geografica
Continente #
EU - Europa 256
NA - Nord America 255
AS - Asia 93
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 8
AF - Africa 5
OC - Oceania 1
Totale 629
Nazione #
US - Stati Uniti d'America 248
DE - Germania 104
FI - Finlandia 61
IT - Italia 59
SG - Singapore 40
CN - Cina 25
SE - Svezia 11
IN - India 8
BR - Brasile 7
VN - Vietnam 7
GB - Regno Unito 5
RU - Federazione Russa 5
CA - Canada 3
HK - Hong Kong 3
IR - Iran 3
NL - Olanda 3
FR - Francia 2
MX - Messico 2
TR - Turchia 2
UA - Ucraina 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
GT - Guatemala 1
IL - Israele 1
MA - Marocco 1
MD - Moldavia 1
NI - Nicaragua 1
PH - Filippine 1
RO - Romania 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 618
Città #
Munich 100
Helsinki 44
San Jose 34
Chandler 30
Ashburn 26
Catanzaro 23
Dallas 17
Singapore 17
Santa Clara 9
Turku 9
Los Angeles 7
Bengaluru 6
Boardman 6
Council Bluffs 6
Hefei 6
Lawrence 6
Milan 6
Phoenix 6
Princeton 6
Beijing 5
Chicago 5
Collegeville 5
Jyväskylä 5
London 5
Des Moines 4
Ho Chi Minh City 3
Hong Kong 3
Induno Olona 3
Denver 2
Johannesburg 2
Messina 2
Oderzo 2
Redwood City 2
West Jordan 2
Wilmington 2
Amsterdam 1
Ankara 1
Araguaína 1
Barueri 1
Brooklyn 1
Cachoeiras de Macacu 1
Cacuaco 1
Cantemir 1
Cittanova 1
Esslingen am Neckar 1
Grafenau 1
Guatemala City 1
Holyoke 1
Juneau 1
Kartepe 1
Khulna 1
Knightdale 1
Lugo 1
Managua 1
Martinsville 1
Mazatlán 1
Mexico City 1
Montreal 1
Nador 1
New York 1
Nijmegen 1
Olomouc 1
Orem 1
Ottawa 1
Paris 1
Pune 1
Rome 1
Shanghai 1
Stockholm 1
Subic 1
Sydney 1
São Bento 1
São Paulo 1
Taormina 1
Tashkent 1
Taubaté 1
Tehran 1
The Dalles 1
Timisoara 1
Toronto 1
Washington 1
Wylie 1
Totale 463
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 266
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 83
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 80
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 71
Clinically relevant drug interactions between statins and antidepressants 69
Safety profile of biologics used in rheumatology: An italian prospective pharmacovigilance study 60
Totale 629
Categoria #
all - tutte 4.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.185


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 0 1 1 0 2 0 2 6 1
2022/202374 12 13 1 11 4 2 1 5 7 6 10 2
2023/202437 6 2 3 2 3 7 0 1 0 3 6 4
2024/2025208 8 0 3 0 11 36 52 29 35 2 17 15
2025/2026165 16 19 21 14 19 9 16 9 18 13 11 0
2026/202765 7 8 28 10 12 0 0 0 0 0 0 0
Totale 629